Facultad de Medicina (FM)
Centro académico
University of Lorraine
Nancy, FranciaPublikationen in Zusammenarbeit mit Forschern von University of Lorraine (11)
2024
-
EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 7, pp. 1891-1908
-
Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial
Hypertension Research
-
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
Heart, Vol. 110, Núm. 19, pp. 1180-1187
2023
-
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
JHEP Reports, Vol. 5, Núm. 5
-
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
Circulation: Heart Failure, Vol. 16, Núm. 5, pp. E009694
2022
-
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331
2020
-
A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 40, Núm. 5, pp. 1370-1382
-
Postoperative Radiation Therapy in Patients with Extracranial Chondrosarcoma: A Joint Study of the French Sarcoma Group and Rare Cancer Network
International Journal of Radiation Oncology Biology Physics
2019
-
CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation: Mechanistic insights and clinical implications
Hypertension, Vol. 73, Núm. 3, pp. 602-611
-
Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure
Heart, Vol. 105, Núm. 4, pp. 307-314
2018
-
Role of amino-acid PET in high-grade gliomas: Limitations and perspectives
Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 62, Núm. 3, pp. 254-266